Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
1 clinical trials · Condition
◉ Watch Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment (NCT05597085) | Pfizer | 2023-03-08 |
Track Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.